Nature Reviews Immunology

Volume 8, No 7 July 2008

Featured Article

Deubiquitylation and regulation of the immune response

Shao–Cong Sun

CURRENT ISSUE

Review

article graphic
Unravelling the association of partial T–cell immunodeficiency and immune dysregulation

Adrian Liston, Anselm Enders & Owen M. Siggs

Surprisingly, and somewhat counter–intuitively, partial T–cell immunodeficiencies are commonly associated with hyper–immune dysregulation. Here, the authors review the genetic basis of such immunodeficiencies and draw on mouse models to provide a potential explanation for the coexistence of immunodeficiency and autoimmunity.

CURRENT ISSUE

Review

article graphic
Interferon–inducible antiviral effectors

Anthony J. Sadler & Bryan R. G. Williams

Type I interferons (IFNs) provide the first line of defence against viral infection. As discussed in this Review, the IFN–induced antiviral effector proteins, such as ISG15, Mx proteins, ribonuclease L and protein kinase R, are important components of this response.

CURRENT ISSUE

Review

article graphic
Colony–stimulating factors in inflammation and autoimmunity

John A. Hamilton

As discussed in this article, in addition to their role as haematopoietic–cell growth factors, colony–stimulating factors have broader roles in immunity, and targeting these factors might have therapeutic benefits in inflammation and autoimmunity.

CURRENT ISSUE

Review

article graphic
Ageing and life–long maintenance of T–cell subsets in the face of latent persistent infections

Janko Nikolich–Z caronugich

A decline in T–cell immunity is a major cause of morbidity and mortality from infectious diseases in the elderly. Janko Nikolich–Z caronugich weighs up the relative roles of and the interplay between homeostatic factors and persistent viruses in immune senescence.

CURRENT ISSUE

Progress

article graphic
Multifunctional roles for MALT1 in T–cell activation

Margot Thome

Recent research on MALT1 (mucosa–associated–lymphoid–tissue lymphoma–translocation gene 1), a protein essential for nuclear factor–κB (NF–κB) activation, has uncovered new mechanisms by which MALT1 can orchestrate intracellular signalling events. Here, Margot Thome highlights recent progress which characterizes how the protease and scaffolding functions of MALT1 modulate T–cell activation.

More Immunology

Noticeboard

Focus on Mucosal Immunology

This Focus from Nature Reviews Immunology highlights the latest advances in our understanding of host–microbe interactions at mucosal sites and the consequences of immune dysregulation at these sites.

Focus on Natural Killer Cells

Nature Immunology presents a series of specially commissioned articles that focus on the differentiation, responsiveness and biological roles of natural killer cells. The focus is available free to registrants for 6 months.

Focus on Allergy and Asthma

Millions of people worldwide suffer from respiratory diseases such as allergies, asthma and chronic obstructive pulmonary disease, and these diseases constitute a major public health burden. This Focus issue highlights the latest advances in our understanding of the immune bases of these diseases and outlines how this knowledge can be translated into more effective treatment strategies.

Poster on innate immunity: sensing and signalling

This poster provides an overview of the components and networks involved in pathogen sensing and signalling in the innate immune system. The poster is freely available thanks to support from MedImmune.

Web Focuses

Please visit our Web Focuses, which provide a selection of articles on a related theme drawn from Nature Publishing Group on key current topics of immunology.

Posters

Our Posters provide a visual overview of a hot topic in immunology. Thanks to generous support, they are freely available and can be viewed online as a high–resolution PDF.

Focus on Antivirals

This joint Web Focus from Nature Reviews Drug Discovery and Nature Biotechnology hosts a collection of reviews, research highlights and commentaries covering the science and business of antiviral drug R&D. Thanks to the generous support of Pfizer (principal sponsor) and Gilead (supporting sponsor), content in the focus is freely available until June 2008.

Journal Citation Reports, Thomson, 2007

Top

Extra navigation

Subscribe

Subscribe to Nature Reviews Immunology


natureproducts


Advertisement